VSIG8 and neoplasm: To investigate the molecular mechanisms underlying tumor-mediated T-cell inhibition, we examined whether MB tumor cells express either of VISTA’s binding partners implicated in T-cell suppression, VSIG3 and VSIG8 [35,36].